Consulting
Executing a Successful Clinical Strategy
A clinical development plan is designed to bring an investigational medicinal product to market through outlining risks and opportunities to a program.
Trend Forecasting: What Does 2022 Have In Store for Clinical Research?
What will be the 2022 trends in clinical research? In this episode, we forecast what is coming up for clinical trials.
Critical Steps for Writing an Impactful Clinical Audit Report
In this blog, we share tips and best practices for writing an impactful clinical audit report.
Understanding Various Decentralized Terms in Research
Virtual, remote, hybrid, decentralized, mHealth, telehealth: Find out what these terms mean for clinical research.
GDPR Implementation Support
Learn how Advarra’s global consulting expertise enabled iSpecimen to implement GDPR with no service interruption to their customers.
Navigating the FDA Emergency Use Filing Process
Partnering with Advarra, one nonprofit successfully obtained an Emergency Use Authorization from the FDA within five weeks.
Developing an Emergency Preparedness Plan for your HRPP
Emergency preparedness plans help institutions plan, prepare for, and respond to emergencies as they arise.
For FDA Inspection Readiness, Accountability is Key
An Advarra expert provides insight in this Q&A session on the FDA inspection readiness process, including how to improve current workflows.
Study Startup Support Info Sheet
Advarra provides flexible solutions that help accelerate the initial IRB review process and make it more efficient.
Top 10 Educational Resources of 2021
In this blog, we take a look at popular blog posts and webinars in 2021 garnering the most interest from research community members like you.
Q&A: FDA Updates: BIMO – What Sponsors Need to Know
Advarra experts Joan Versaggi and Leslie Paul answer questions from the webinar- FDA Updates: BIMO – What Sponsors Need to Know.
The Key to Increasing Diversity in Decentralized Trials
Rosamund Round VP of Parexel’s Patient Innovation Center and DCTs shares key strategies for increasing diversity in decentralized trials.